Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$14.59 USD
-0.25 (-1.68%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $14.61 +0.02 (0.14%) 5:34 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.97 |
EPS Last Quarter | -1.08 |
Last EPS Surprise | 0.92% |
ABR | 1.20 |
Earnings ESP
|
-25.39% |
---|---|
Current Year | -3.59 |
Next Year | -3.59 |
EPS (TTM) | -4.15 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 26.15M | 110.72M | 179.75M | 127.75M |
# of Estimates | 3 | 3 | 4 | 4 |
High Estimate | 31.00M | 276.15M | 355.00M | 202.00M |
Low Estimate | 22.45M | 25.00M | 100.00M | 100.00M |
Year ago Sales | 25.00M | 29.00M | 117.00M | 179.75M |
Year over Year Growth Est. | 4.60% | 281.78% | 53.63% | -28.93% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.97 | -0.99 | -3.59 | -3.59 |
# of Estimates | 2 | 2 | 5 | 4 |
Most Recent Consensus | -0.72 | -0.71 | -3.27 | -3.70 |
High Estimate | -0.72 | -0.71 | -2.94 | -2.41 |
Low Estimate | -1.21 | -1.26 | -4.92 | -4.68 |
Year ago EPS | -1.09 | -1.04 | -4.15 | -3.59 |
Year over Year Growth Est. | 11.01% | 4.81% | 13.49% | -0.07% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 4 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.97 | -0.99 | -3.59 | -3.59 |
7 Days Ago | -0.97 | -0.99 | -3.59 | -3.59 |
30 Days Ago | -0.72 | -0.71 | -3.16 | -2.99 |
60 Days Ago | NA | NA | -2.87 | -2.77 |
90 Days Ago | NA | NA | -3.89 | -3.46 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.21 | -1.26 | -4.92 | -4.68 |
Zacks Consensus Estimate | -0.97 | -0.99 | -3.59 | -3.59 |
Earnings ESP | -25.39% | -27.92% | -37.05% | -30.27% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.08 | -0.94 | -1.04 | -1.09 | NA |
Estimate | -1.09 | -1.12 | -1.00 | -1.06 | NA |
Difference | 0.01 | 0.18 | -0.04 | -0.03 | 0.03 |
Surprise | 0.92% | 16.07% | -4.00% | -2.83% | 2.54% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more